Matrix-Gla protein and vascular calcification: the negative role of oral anticoagulant therapy.
Mario
M
Cozzolino
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001021:Aortic Valve / Q000187:drug effects; D015415:Biomarkers / Q000097:blood; D002114:Calcinosis / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D002135:Calcium-Binding Proteins / Q000097:blood*; D002908:Chronic Disease; D015536:Down-Regulation; D016326:Extracellular Matrix Proteins / Q000097:blood*; D005919:Glomerular Filtration Rate; D006349:Heart Valve Diseases / Q000097:blood / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000503:physiopathology; D011379:Prognosis; D014652:Vascular Diseases / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000097:blood; D000097568:Matrix Gla Protein
D000925:Anticoagulants; D015415:Biomarkers; D002135:Calcium-Binding Proteins; D016326:Extracellular Matrix Proteins; D014812:Vitamin K; D000097568:Matrix Gla Protein